Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

The man's rash, hair loss, and vision issues were due to syphilis, not CMV.

Low-dose isotretinoin is effective for treating pediatric scarring alopecia.

Fibroblasts from healthy donors can prevent changes seen in recessive epidermolysis bullosa simplex.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

OCT can non-invasively diagnose follicular keratosis and other hair follicle disorders.

Dermoscopy improves diagnosis and treatment planning for trichostasis spinulosa.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Early diagnosis, stopping the suspected drug, and supportive care are crucial for treating Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Early detection of Graham-Little-Piccardi-Lasseur syndrome is key for better management.

Dermoscopy helped diagnose discoid lupus erythematosus in two patients without needing skin biopsies.

A man's skin condition and poor diet led to a scurvy diagnosis.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Uveodermatological syndrome in dogs is hard to manage and can lead to blindness despite treatment.

The improved tretinoin lotion effectively treats acne with minimal irritation, even in children as young as 9.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Higher RBP4 levels found in people with two types of hair loss.

A rare scalp condition was successfully treated with specific medications after 9 months.

Tislelizumab can cause cutaneous lupus erythematosus.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Retinoids are effective for acne but can cause serious side effects.